GlassVC
No published image.

Geeta Vemuri

Managing Partner, Founder · Agent Capital

FounderWaltham, MA

Geeta Vemuri is Founder and Managing Partner of Agent Capital, a Boston-area life sciences investment firm she founded in 2016 focused on novel, differentiated therapeutics. She previously was Managing Partner of Baxter Ventures and Baxalta Ventures and a Partner at Quaker Partners, and holds a PhD in biochemistry and a Wharton MBA.

Board seats

61 current

· PUBLIC SOURCES

Credited hits

7

· PUBLIC SOURCES

Midas years

No public record

LAST CHECKED NOV 2026

Founder rating

No public record

LAST CHECKED NOV 2026

Maintained from public sources. Not claimed. If you're Geeta Vemuri, you can claim this profile.

Claim this profileHow claiming works

Claiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.

Track record

Credited deals only — Geeta Vemuri is named in a public source as investor, lead, or board member on these deals. This is not a complete investment history, and absence here is not evidence of absence.
  • Covagenacquired

    Named in Geeta Vemuri's Agent Capital bio among companies whose board she served on; acquired by J&J.

    Source: agentcapital.com

  • Gadetaacquired

    Named in Geeta Vemuri's Agent Capital bio among companies whose board she served on; acquired by Gilead.

    Source: agentcapital.com

  • Naurexacquired

    Named in Geeta Vemuri's Agent Capital bio among companies whose board she served on; acquired by Allergan.

    Source: agentcapital.com

  • Protez Pharmaceuticalsacquired

    Named in Geeta Vemuri's Agent Capital bio among companies whose board she served on; acquired by Novartis.

    Source: agentcapital.com

  • Syntimmuneacquired

    Named in Geeta Vemuri's Agent Capital bio among companies whose board she served on; acquired by Alexion.

    Source: agentcapital.com

  • True North Therapeuticsacquired

    Named in Geeta Vemuri's Agent Capital bio among companies whose board she served on; acquired by Bioverativ/Sanofi.

    Source: agentcapital.com

  • Cempraipo

    Named in Geeta Vemuri's Agent Capital bio among companies whose board she served on until its IPO (and her 2011 departure).

    Source: agentcapital.com

Board seats

Current board seats · 1

Also on record · 5

Success signals

Forbes Midas List

No public record

Not listed.

Reputation

No reputation score — basis not established for this investor.

Contact

Published sources only

Published contact details collected from public sources. Not a referral, and not an introduction.

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

Claimed profiles can replace or remove contact details.

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Geeta Vemuri. Reviews come from founders whose identity and relationship have been verified.

Write the first review
Reviews of Agent Capital (0) →

Firm-level reviews are not attributed to Geeta Vemuri.

Methodology

This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.

Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.

Corrections with a source: Suggest a correction.

Source record 1

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Geeta Vemuri — provenance: GlassVC catalog

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals · Board seats · Reputation

EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026